Annual CFO
-$116.59 M
-$73.81 M-172.54%
December 31, 2024
Summary
- As of March 12, 2025, MLTX annual cash flow from operations is -$116.59 million, with the most recent change of -$73.81 million (-172.54%) on December 31, 2024.
- MLTX annual CFO is now -172.54% below its all-time high of -$42.78 million, reached on December 31, 2023.
Performance
MLTX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$48.47 M
-$23.20 M-91.79%
December 31, 2024
Summary
- As of March 12, 2025, MLTX quarterly cash flow from operations is -$48.47 million, with the most recent change of -$23.20 million (-91.79%) on December 31, 2024.
- Over the past year, MLTX quarterly CFO has dropped by -$23.20 million (-91.79%).
- MLTX quarterly CFO is now -437.14% below its all-time high of -$9.02 million, reached on March 31, 2023.
Performance
MLTX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$116.59 M
-$36.13 M-44.90%
December 31, 2024
Summary
- As of March 12, 2025, MLTX TTM cash flow from operations is -$116.59 million, with the most recent change of -$36.13 million (-44.90%) on December 31, 2024.
- Over the past year, MLTX TTM CFO has dropped by -$36.13 million (-44.90%).
- MLTX TTM CFO is now -721.85% below its all-time high of -$14.19 million, reached on March 31, 2022.
Performance
MLTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MLTX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -172.5% | -91.8% | -44.9% |
| 3 y3 years | - | -437.1% | -129.8% |
| 5 y5 years | - | -437.1% | -129.8% |
MLTX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -172.5% | at low | -437.1% | at low | -721.9% | at low |
| 5 y | 5-year | -172.5% | at low | -437.1% | at low | -721.9% | at low |
| alltime | all time | -172.5% | at low | -437.1% | at low | -721.9% | at low |
MoonLake Immunotherapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$116.59 M(+172.5%) | -$48.47 M(+91.8%) | -$116.59 M(+44.9%) |
| Sep 2024 | - | -$25.27 M(-9.4%) | -$80.46 M(+24.9%) |
| Jun 2024 | - | -$27.89 M(+86.6%) | -$64.43 M(+32.3%) |
| Mar 2024 | - | -$14.95 M(+21.1%) | -$48.70 M(+13.8%) |
| Dec 2023 | -$42.78 M | -$12.34 M(+33.4%) | -$42.78 M(+1.8%) |
| Sep 2023 | - | -$9.25 M(-23.9%) | -$42.03 M(-0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$12.16 M(+34.7%) | -$42.13 M(-17.0%) |
| Mar 2023 | - | -$9.02 M(-22.2%) | -$50.73 M(-9.2%) |
| Dec 2022 | -$55.89 M | -$11.60 M(+24.0%) | -$55.89 M(+26.2%) |
| Sep 2022 | - | -$9.35 M(-55.0%) | -$44.30 M(+26.8%) |
| Jun 2022 | - | -$20.76 M(+46.3%) | -$34.95 M(+146.3%) |
| Mar 2022 | - | -$14.19 M | -$14.19 M |
FAQ
- What is MoonLake Immunotherapeutics annual cash flow from operations?
- What is the all time high annual CFO for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual CFO year-on-year change?
- What is MoonLake Immunotherapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly CFO year-on-year change?
- What is MoonLake Immunotherapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics TTM CFO year-on-year change?
What is MoonLake Immunotherapeutics annual cash flow from operations?
The current annual CFO of MLTX is -$116.59 M
What is the all time high annual CFO for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual cash flow from operations is -$42.78 M
What is MoonLake Immunotherapeutics annual CFO year-on-year change?
Over the past year, MLTX annual cash flow from operations has changed by -$73.81 M (-172.54%)
What is MoonLake Immunotherapeutics quarterly cash flow from operations?
The current quarterly CFO of MLTX is -$48.47 M
What is the all time high quarterly CFO for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly cash flow from operations is -$9.02 M
What is MoonLake Immunotherapeutics quarterly CFO year-on-year change?
Over the past year, MLTX quarterly cash flow from operations has changed by -$23.20 M (-91.79%)
What is MoonLake Immunotherapeutics TTM cash flow from operations?
The current TTM CFO of MLTX is -$116.59 M
What is the all time high TTM CFO for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high TTM cash flow from operations is -$14.19 M
What is MoonLake Immunotherapeutics TTM CFO year-on-year change?
Over the past year, MLTX TTM cash flow from operations has changed by -$36.13 M (-44.90%)